Valued at $26.8 billion by market cap, Mettler-Toledo International Inc. (MTD) is a global provider of precision instruments and analytical solutions used in laboratory, industrial, and retail settings. Based in Columbus, Ohio, the company is best known for its high-accuracy weighing equipment and measurement technologies that are critical to quality control, research, and regulatory compliance.
The leading precision instruments supplier is expected to announce its fiscal 2026 first-quarter earnings after the market closes on Thursday, May 7. Ahead of the event, analysts expect MTD to report a profit of $8.70 per share on a diluted basis, up 6.2% from $8.19 per share in the year-ago quarter. The company has consistently surpassed Wall Street’s EPS estimates in its last four quarterly reports.
More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.
For the current year, analysts expect MTD to report EPS of $46.51, up 8.9% from $42.73 in fiscal 2025. Its EPS is expected to rise 10.4% year over year to $51.33 in fiscal 2027.
www.barchart.comMTD stock has soared 30.6% over the past year, underperforming the S&P 500 Index’s ($SPX) 35% gains but outpacing Health Care Select Sector SPDR Fund’s (XLV) 8.4% returns over the same time frame.
www.barchart.comOn Apr. 17, shares of Mettler-Toledo inched 3.5% in the afternoon session as easing geopolitical tensions and the reopening of the Strait of Hormuz helped reduce energy and logistics costs. Lower transportation and operating expenses support margins across healthcare and life sciences customers, while improving market sentiment is encouraging renewed investment in biotech and pharmaceutical research, key end markets for MTD’s precision instruments.
Analysts’ consensus opinion on MTD stock is moderately bullish, with a “Moderate Buy” rating overall. Out of 14 analysts covering the stock, seven advise a “Strong Buy” rating, and seven give a “Hold.” MTD’s average analyst price target is $1,500.62, indicating a potential upside of 14.5% from the current levels.
On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
More news from Barchart
Is a Giant Short Squeeze in Allbirds Stock Brewing Before May? 2 Tech Stock Analysts Believe Can Bounce 70% or More Over the Next 12 Months TSLA Stock: 4 Key Things to Watch When Tesla Reports Q1 Earnings Should You Buy AMD Stock Before Earnings on May 5? GF Securities Says Yes.